Trial Details

COMPLETED
Basic Information
Clinical ID c9
Identifier NCT06856031
Trial Title the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions IBD (Inflammatory Bowel Disease)
Interventions DRUG: Optimized Treatment (OPT)
Participant Information
Sponsor Second Affiliated Hospital of Wenzhou Medical University
City Wenzhou
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2020-11-01
Primary Completion Date 2024-11-30
Completion Date 2024-11-30